Cardinal Health stock gets January dividend after board approval
Published on 11/13/2026 at 12:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSPayment schedule and investor context
- Cardinal Health's board approved a quarterly dividend funded from the company's capital surplus.
- The payment is scheduled for January 15, 2027, for shareholders of record at the close of business on January 4, 2027.
- Cardinal Health distributes pharmaceuticals and medical products and provides healthcare services.
Cardinal Health's board approved a quarterly dividend of 0.5158 US dollars per share on Wednesday, November 11, the company said in a Cardinal Health newsroom release. The dividend will be paid from the company's capital surplus.
Payment is scheduled for Friday, January 15, 2027. Shareholders must be recorded at the close of business on Monday, January 4, 2027, to receive the distribution. The announcement adds a defined payment date to the company's shareholder calendar as Cardinal Health enters the second quarter of its fiscal year 2027.
What the dividend means for shareholders
The board decision provides a scheduled cash distribution for eligible shareholders, but the release does not link the payment to a change in the company's operating outlook. Cardinal Health's business spans pharmaceutical distribution, medical products, home-health and direct-to-patient services, nuclear pharmacies, manufacturing facilities, and performance and data solutions.
Cardinal Health stock traded at 252.60 euros on Lang & Schwarz at 12:44 CET on Friday, November 13. The quotation is an intraday indication and does not establish a direction against an Xetra closing price.
Cardinal Health stock at a glance
- Company: Cardinal Health, Inc.
- ISIN: US14149Y1082
- WKN: 880206
- Ticker: CAH
- Home exchange: NYSE
- Lang & Schwarz quote: 252.60 euros at 12:44 CET on November 13, 2026
- Quarterly dividend: 0.5158 US dollars per share
- Record date: January 4, 2027
- Payment date: January 15, 2027
- Sector: Healthcare
US equity markets remain the broader backdrop for investors following Cardinal Health stock, with the S&P 500 market theme providing the relevant benchmark context.
